Vertex Pharmaceuticals Incorporated

(VRTX) Trade

By |

Profile

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Contact Information

Website: www.vrtx.com
Email: investorinfo@vrtx.com
Main Phone: +1 617 341-6100
Address: 50 Northern Avenue
State: MA
City / Town: Boston
Country: USA
Postal Code: 02210

Issuer Information

Exchange: NGS
CEO: Jeffrey M Leiden
Employees: 2500
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Contact Information

Website: www.vrtx.com
Email: investorinfo@vrtx.com
Main Phone: +1 617 341-6100
Address: 50 Northern Avenue
State: MA
City / Town: Boston
Country: USA
Postal Code: 02210

Issuer Information

Exchange: NGS
CEO: Jeffrey M Leiden
Employees: 2500
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 229.06 $ -4.85 (-2.07%)
Last Price 229.06 Change $ -4.85 Change % -2.07 Tick N/A
Bid 227.26 Bid Size 100.00 Ask 229.06 Ask Size 200.00
Open 234.07 High 235.18 Low 228.42 Prev Close 233.91
Last Trade Volume 904,271 52 Wk Hi 237.48 52 Wk Low 163.69
Market Cap 58.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 257,149,588.00 EPS (TTM) 8.26 PE Ratio 27.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 42 396
Number of Buys 20 133
Number of Sells 22 263
Net Activity -13288 -379961
Last 10 Buys Shares
Margaret G. McGlynn 1,000
Jeffrey M Leiden 1,000
Jeffrey M Leiden 1,000
Dennis L. Winger 1,000
Last 10 Sell Shares
Sangeeta N. Bhatia 1,000
Paul M. Silva 1,000
Michael Parini 1,000
Ian F. Smith 1,000
David Altshuler 1,000
Amit K. Sachdev 1,000
Stuart A. Arbuckle 1,000
Ian F. Smith 1,000
Michael Parini 1,000
Michael Parini 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 212 212 212 212
Low Target Price Estimate 103 103 103 103
Mean Target Price Estimate 188.65 188.65 188.65 188.65
Standard Deviation 24.22 24.22 24.22 24.22
Date of Most Recent Estimate 05/30/18 05/14/18 05/14/18 05/30/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 15 15 15 16
Moderate Buy 4 4 4 4
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.36 1.36 1.34